Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Rating of “Buy” by Brokerages

Scholar Rock Holding Corporation (NASDAQ:SRRK) has been assigned an average recommendation of “Buy” from the seventeen brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a buy recommendation and four have issued a strong buy recommendation on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $54.3571.

Several equities research analysts have commented on SRRK shares. Truist Financial lifted their price objective on shares of Scholar Rock from $44.00 to $55.00 and gave the company a “buy” rating in a report on Tuesday, March 3rd. Weiss Ratings restated a “sell (d-)” rating on shares of Scholar Rock in a research report on Thursday, January 22nd. JPMorgan Chase & Co. lifted their price target on Scholar Rock from $47.00 to $50.00 and gave the company an “overweight” rating in a research note on Monday, March 16th. Barclays upped their price target on Scholar Rock from $52.00 to $53.00 and gave the stock an “overweight” rating in a report on Tuesday, March 3rd. Finally, Piper Sandler increased their price target on Scholar Rock from $51.00 to $58.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 4th.

Insider Buying and Selling at Scholar Rock

In other Scholar Rock news, insider Mo Qatanani sold 8,484 shares of Scholar Rock stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $47.07, for a total value of $399,341.88. Following the sale, the insider owned 98,445 shares in the company, valued at $4,633,806.15. The trade was a 7.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Caryn Parlavecchio sold 9,035 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $46.53, for a total value of $420,398.55. Following the transaction, the insider owned 169,087 shares of the company’s stock, valued at approximately $7,867,618.11. This represents a 5.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 207,464 shares of company stock worth $9,157,423 over the last three months. 13.30% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Scholar Rock

Institutional investors have recently bought and sold shares of the company. Siren L.L.C. raised its holdings in shares of Scholar Rock by 17.0% in the 4th quarter. Siren L.L.C. now owns 10,825,013 shares of the company’s stock valued at $476,842,000 after purchasing an additional 1,575,008 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Scholar Rock by 26.7% during the fourth quarter. Wellington Management Group LLP now owns 5,759,428 shares of the company’s stock worth $253,703,000 after purchasing an additional 1,213,541 shares in the last quarter. Vanguard Group Inc. increased its holdings in Scholar Rock by 5.7% in the fourth quarter. Vanguard Group Inc. now owns 5,195,465 shares of the company’s stock valued at $228,860,000 after buying an additional 280,538 shares during the last quarter. State Street Corp raised its stake in Scholar Rock by 7.2% in the fourth quarter. State Street Corp now owns 4,034,434 shares of the company’s stock valued at $177,717,000 after buying an additional 271,331 shares in the last quarter. Finally, Orbis Allan Gray Ltd raised its stake in Scholar Rock by 1,034.5% in the fourth quarter. Orbis Allan Gray Ltd now owns 3,428,929 shares of the company’s stock valued at $151,044,000 after buying an additional 3,126,677 shares in the last quarter. 91.08% of the stock is owned by institutional investors and hedge funds.

Scholar Rock Stock Performance

NASDAQ SRRK opened at $42.60 on Monday. Scholar Rock has a 52 week low of $22.71 and a 52 week high of $49.82. The company has a 50 day moving average price of $45.06 and a 200 day moving average price of $40.42. The company has a quick ratio of 6.95, a current ratio of 6.95 and a debt-to-equity ratio of 0.41. The firm has a market cap of $4.89 billion, a PE ratio of -12.42 and a beta of 0.70.

Scholar Rock (NASDAQ:SRRK) last announced its earnings results on Tuesday, March 3rd. The company reported ($0.76) earnings per share for the quarter, topping the consensus estimate of ($0.86) by $0.10. During the same period in the previous year, the company earned ($0.64) EPS. As a group, sell-side analysts forecast that Scholar Rock will post -2.42 EPS for the current fiscal year.

Scholar Rock Company Profile

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).